• Company
• Potential of AVEO Oncology acquired by LG Chem
• by Jan 24, 2024 05:46am

• Company
• ‘I believe in MSD Korea and the Korean government'
• by Eo, Yun-Ho Jan 24, 2024 05:46am

• Policy
• Handok-Sanofi launches hypertension combo drug Aprovasc
• by Lee, Tak-Sun Jan 24, 2024 05:45am

• Policy
• New drug Zavicefta Inj, and more completed drug pricing nego
• by Lee, Tak-Sun Jan 23, 2024 06:02am

• Policy
• Samsung Bioepis receives approval for its Soliris biosimilar
• by Lee, Hye-Kyung Jan 23, 2024 06:02am

• Company
• SGLT2i+DPP4i combos' performance falls short of expectations
• by Kim, Jin-Gu Jan 23, 2024 06:02am

• Policy
• Korean patients pay ₩10.5M for ₩300M Luxturna
• by Lee, Tak-Sun Jan 23, 2024 06:02am

• Company
• Will Verzenio secure expansion for early breast cancer?
• by Eo, Yun-Ho Jan 23, 2024 06:02am

• Policy
• Luxturna, Kerendia, & Raspirin will get new reimb standards
• by Lee, Jeong-Hwan Jan 22, 2024 05:49am

• Company
• Sotatercept receives orphan drug designation in Korea
• by Eo, Yun-Ho Jan 22, 2024 05:49am